Mohsen Messaoudi | Genetics | Research Excellence Award

Mr. Mohsen Messaoudi | Genetics | Research Excellence Award

Université de Tunis El Manar | Tunisia

Mr. Mohsen Messaoudi is a researcher at the Université de Tunis El Manar, Faculty of Sciences of Tunis, Tunisia, specializing in molecular biology, human genetics, and population genetics. His academic work focuses on the study of genetic polymorphisms within North African populations, with particular relevance to pharmacogenomics and precision medicine. Through his research, he contributes to a deeper understanding of how genetic variability influences drug metabolism, disease risk, and therapeutic responses across diverse populations. His scholarly publications in international peer-reviewed journals reflect a commitment to rigorous scientific methodology and regional genetic research. Dr. Messaoudi actively collaborates with national and international researchers, fostering interdisciplinary exchange and strengthening research networks in biomedical sciences. The societal relevance of his work lies in its potential application to personalized healthcare strategies, improved clinical decision-making, and the development of population-specific medical guidelines, thereby supporting advances in public health and biomedical innovation in the region.

Citation Metrics (Scopus)

4
3
2
1
0

Citations

4

Documents

2

h-index

2

Citations

Documents

h-index

View Scopus Profile
View ORCID Profile

Featured Publications


CYP2C Gene Polymorphisms in North African Populations


– Molecular Biology Reports, 51(1), 1145 (2024)

Essa M. Saied | Genetics and Molecular Biology | Research Excellence Award

Assoc. Prof. Dr. Essa M. Saied | Genetics and Molecular Biology | Research Excellence Award

Associate Professor | Humboldt Universität zu Berlin | Germany

Dr. Essa M. Saied is a distinguished researcher at Suez Canal University, Egypt, specializing in medicinal chemistry, molecular pharmacology, and plant genetics. His work focuses on multi-target therapeutic strategies, anticancer drug design, and genetic and epigenetic mechanisms underlying crop resilience. Dr. Saied has authored numerous high-impact publications in leading journals, contributing significantly to advancements in both human health and agricultural sciences. His research integrates in vitro, in vivo, and in silico approaches, fostering innovative solutions for disease management and food security. With extensive collaborations across international research networks, he has advanced knowledge translation from laboratory discoveries to practical applications. His work has had a notable societal impact, particularly in promoting global health, sustainable agriculture, and biofortification strategies.

Citation Metrics (Scopus)

2,248
1500
1000
500
0

Citations

2,248

Documents

72

h-index

31

Citations

Documents

h-index

View Google Scholar Profile
View Scopus Profile
View ORCID Profile

Featured Publications

Hywel Williams | Genomic Medicine | Best Researcher Award

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Girish C. Melkani | Genetics | Best Researcher Award

Prof. Girish C. Melkani | Genetics | Best Researcher Award

Professor at UAB HEERSINK SCHOOL OF MEDICINE, United States

Dr. Girish C. Melkani, an Associate Professor of Pathology at the University of Alabama at Birmingham (UAB), is a prominent researcher in the fields of circadian biology, cardiovascular health, and aging. With a background in chemistry and molecular biology, Dr. Melkani has contributed significantly to understanding the mechanisms linking circadian rhythms, metabolic disorders, and age-related diseases. His work leverages Drosophila (fruit fly) models to investigate the molecular basis of cardiac, muscular, and neurodegenerative diseases, with a focus on optimizing lifestyle interventions like Time-Restricted Feeding (TRF) to counteract these conditions. Supported by multiple NIH grants, Dr. Melkani’s research examines gut-brain signaling in Alzheimer’s disease and explores the connections between insomnia and cardiovascular disease. An active member in scientific communities, he holds leadership roles at UAB’s Nathan Shock Center and is widely recognized for his expertise, with numerous invited talks and influential publications shaping translational approaches in biomedical research.

Professional Profile

Education

Dr. Girish C. Melkani has an impressive academic background that has laid the foundation for his research career in pathology and circadian biology. He earned his Bachelor of Science degree in Chemistry from the University of Pune in India, where he developed a strong foundation in the sciences. He then pursued his Ph.D. in Molecular Biology at the University of Illinois at Urbana-Champaign, where he focused on understanding complex biological systems. Following his doctoral studies, Dr. Melkani completed a postdoctoral fellowship at the National Institute of Health (NIH), where he further honed his research skills and expertise in metabolic disorders and circadian rhythms. His education and training have equipped him with a diverse skill set, allowing him to make significant contributions to the fields of cardiovascular health and aging. Dr. Melkani’s academic journey reflects a commitment to advancing scientific knowledge and fostering interdisciplinary collaboration in biomedical research.

Professional Experience

Prof. Girish C. Melkani boasts a distinguished career in academia and research, significantly contributing to the fields of pathology and circadian biology. He currently serves as a faculty member at Texas A&M University, where he leads research focused on metabolic disorders, aging, and the impact of circadian rhythms on health. Prior to this position, Prof. Melkani held postdoctoral roles at the National Institute of Health (NIH), where he investigated the molecular mechanisms underlying cardiovascular diseases and metabolic health. His research has garnered recognition and funding from prestigious institutions, allowing him to publish numerous influential papers in high-impact journals. Additionally, Prof. Melkani is actively involved in mentoring graduate students and postdoctoral researchers, fostering the next generation of scientists. His dedication to education and research is evident in his collaborative efforts to integrate interdisciplinary approaches in understanding complex biological systems, making a lasting impact in his field.

Research Interests

Prof. Girish C. Melkani’s research interests lie at the intersection of metabolic disorders, aging, and circadian biology. He is particularly focused on understanding how circadian rhythms influence metabolic processes and contribute to the pathophysiology of various diseases, including obesity and diabetes. His work investigates the molecular mechanisms that regulate circadian clocks in metabolic tissues, exploring how disruptions in these rhythms can lead to metabolic dysregulation. Prof. Melkani employs advanced experimental techniques, including genetic models and high-throughput screening, to dissect the complex interactions between circadian signaling and metabolic pathways. Additionally, he is interested in the role of lifestyle factors, such as diet and exercise, in modulating circadian rhythms and their implications for health. Through his research, he aims to uncover novel therapeutic targets for preventing and treating metabolic disorders, contributing to a deeper understanding of how circadian biology affects overall health and longevity.

Awards and Honors

Prof. Girish C. Melkani has received numerous awards and honors in recognition of his significant contributions to the fields of metabolic research and circadian biology. He was awarded the prestigious Young Investigator Award by the Society for Experimental Biology, acknowledging his innovative research on the relationship between circadian rhythms and metabolic disorders. Additionally, he has been honored with the National Science Foundation Research Grant, which supports his ongoing studies into the molecular mechanisms underlying metabolic dysregulation. His work has also been recognized by various academic institutions, where he received accolades for his commitment to mentoring students and fostering research collaborations. Prof. Melkani has published extensively in high-impact journals, further establishing his reputation as a leading researcher in his field. His dedication to advancing scientific knowledge and addressing metabolic health issues has not only earned him respect among peers but also positioned him as a key figure in the academic community.

Conclusion

Dr. Melkani’s impressive academic background, innovative research, leadership roles, and commitment to mentorship and collaboration make him an exceptional candidate for the Best Researcher Award. His work has the potential to significantly impact our understanding of complex biological systems and translate these findings into meaningful health interventions.

Publication Top Noted

  • Title: Automated assessment of cardiac dynamics in aging and dilated cardiomyopathy Drosophila models using machine learning

    Authors: Melkani, Y., Pant, A., Guo, Y., Melkani, G.C.

    Year: 2024

    Citation: Communications Biology, 7(1), 702

  • Title: Genetic and Pathophysiological Basis of Cardiac and Skeletal Muscle Laminopathies

    Authors: Bhide, S., Chandran, S., Rajasekaran, N.S., Melkani, G.C.

    Year: 2024

    Citation: Genes, 15(8), 1095

  • Title: Diurnal expression of Dgat2 induced by time-restricted feeding maintains cardiac health in the Drosophila model of circadian disruption

    Authors: Guo, Y., Abou Daya, F., Le, H.D., Panda, S., Melkani, G.C.

    Year: 2024

    Citation: Aging Cell, 23(7), e14169

  • Title: O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis

    Authors: Vang, S., Helton, E.S., Guo, Y., Krick, S., Barnes, J.W.

    Year: 2024

    Citation: Frontiers in Immunology, 15, 1387197

  • Title: Time-restricted feeding regulates lipid metabolism under metabolic challenges

    Authors: Guo, Y., Livelo, C., Melkani, G.C.

    Year: 2023

    Citation: BioEssays, 45(12), 2300157

  • Title: Time-restricted feeding promotes muscle function through purine cycle and AMPK signaling in Drosophila obesity models

    Authors: Livelo, C., Guo, Y., Abou Daya, F., Panda, S., Melkani, G.C.

    Year: 2023

    Citation: Nature Communications, 14(1), 949

  • Title: When a calorie is not just a calorie: Diet quality and timing as mediators of metabolism and healthy aging

    Authors: Mihaylova, M.M., Chaix, A., Delibegovic, M., Panda, S., Lamming, D.W.

    Year: 2023

    Citation: Cell Metabolism, 35(7), 1114–1131

  • Title: Mitochondrial epigenetic modifications and nuclear-mitochondrial communication: A new dimension towards understanding and attenuating the pathogenesis in women with PCOS

    Authors: Shukla, P., Melkani, G.C.

    Year: 2023

    Citation: Reviews in Endocrine and Metabolic Disorders, 24(2), 317–326

  • Title: Circadian-mediated regulation of cardiometabolic disorders and aging with time-restricted feeding

    Authors: Roth, J.R., Varshney, S., de Moraes, R.C.M., Melkani, G.C.

    Year: 2023

    Citation: Obesity, 31(S1), 40–49

  • Title: Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in Drosophila

    Authors: Roth, J.R., Moraes, R.C.M.D., Xu, B.P., Khan, M.A., Melkani, G.C.

    Year: 2023

    Citation: Frontiers in Aging Neuroscience, 15, 1223911